Address: Klosters Way, PO-Box 245, Waterville Valley NH 03215
Menu
Client Support
508-944-3260
508-944-3260
“The mission of West Surry Strategies is to accelerate our clients’ value creation through a diversified strategy of experienced program management, innovative design, and cost-saving efficiency from the concept design stage through product and process optimization over the life cycle.
West Surry Strategies has the unique experience to guide firms from design to successful implementation. Our team has the expertise and knowledge to anticipate problems and apply a custom solution that fits your needs.—West Surry Strategies has demonstrated results for our clients in accelerating value creation through a diversified array of services. Please contact us for applicable program examples.
In addition to concept generation and product development, we are highly effective at aiding in resolving delayed projects...
We are leaders in Value Analysis/Value Engineering (VA/VE) methodologies. Our team engages with our clients to evaluate...
We have expertise in identifying and resolving product and process issues. Our team engages with our clients' customers and supply chain...
On April 23, 2015, the Senate Committee on Finance Subcommittee on Health Care held a hearing titled, “A Fresh Look at the Impact of the Medical Device Tax on Jobs, Innovation, and Patients.” Founder and CEO Quinton Farrar was asked by Subcommittee Chairman Patrick Toomey to testify before the Committee on his experience in the medical device industry. You can watch the full hearing here.
A medical device industry executive with broad operational experience. Quinton has served in executive roles for 20 years and has 30 years of medical device experience.
Prior to founding West Surry Strategies, Quinton held VP roles in research & development as well as operations at Smiths Medical. Before Smiths, Quinton was the Sr. VP Technology Development/RA/QA with Genzyme Biosurgical. He joined Genzyme when they acquired the privately held medical device manufacturer Deknatel Snowden-Pencer where he was the Executive VP of Technology Development. Quinton had a leadership role in taking this firm private during a management buyout from Pfizer hospital products. During his tenure with the Pfizer division, Deknatel, he served as a Project Engineer, Director, and VP of product development as well as the Group VP of Blood Recovery.
Quinton has a BSME from Fairleigh Dickinson University. He lives in Keene, NH.
Founder and CEO
Our proprietary network forms the group of experienced and proven resources. Our capabilities are applied in proportion to the technical requirements of the program, the principle of the sharing economy. We manage all programs with a focus on costs effective methodologies to achieve results and minimize cycle time.
Our proprietary network forms the group of experienced and proven resources. Our capabilities are applied in proportion to the technical requirements of the program, the principle of the sharing economy. We manage all programs with a focus on costs effective methodologies to achieve results and minimize cycle time.
Follow Us:
© Copyright 2024 West Surry Strategies, LLC | all right reserved